The best news from Yemen on health and wellness

Provided by AGP

Yemen Health Report
Got News to Share?
Got News to Share? Explore more publications!

Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 4, 2026

CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
May. 4, 2026

CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

Indeterminate GlobeNewswire
REGIONAL HEALTH PROPERTIES ANNOUNCES APPOINTMENT OF MARLIE DAVIS AS CHIEF FINANCIAL OFFICER
May. 4, 2026

REGIONAL HEALTH PROPERTIES ANNOUNCES APPOINTMENT OF MARLIE DAVIS AS CHIEF FINANCIAL OFFICER

Indeterminate GlobeNewswire
Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
May. 4, 2026

Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference

Indeterminate GlobeNewswire
CooperCompanies Appoints Paul Keel to its Board of Directors
May. 4, 2026

CooperCompanies Appoints Paul Keel to its Board of Directors

Indeterminate GlobeNewswire
InspireMD Reports First Quarter 2026 Financial Results
May. 4, 2026

InspireMD Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Option Care Health to Participate in the Bank of America Health Care Conference
May. 4, 2026

Option Care Health to Participate in the Bank of America Health Care Conference

Indeterminate GlobeNewswire
Kyntra Bio to Report First Quarter 2026 Financial Results
May. 4, 2026

Kyntra Bio to Report First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12
May. 4, 2026

Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12

Indeterminate GlobeNewswire
Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital
May. 4, 2026

Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital

Indeterminate GlobeNewswire
Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
May. 4, 2026

Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Indeterminate GlobeNewswire
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May. 4, 2026

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
ORIC® Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Updates
May. 4, 2026

ORIC® Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Updates

Indeterminate GlobeNewswire
Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance
May. 4, 2026

Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance

Indeterminate GlobeNewswire
Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes
May. 4, 2026

Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes

Indeterminate GlobeNewswire
Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference
May. 4, 2026

Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference

Indeterminate GlobeNewswire
FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring
May. 4, 2026

FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring

Indeterminate GlobeNewswire
Biodesix Announces First Quarter 2026 Results and Highlights
May. 4, 2026

Biodesix Announces First Quarter 2026 Results and Highlights

Indeterminate GlobeNewswire
Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May. 4, 2026

Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire
Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares 
May. 4, 2026

Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares 

Indeterminate GlobeNewswire
Cytokinetics to Announce Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy, on May 5, 2026
May. 4, 2026

Cytokinetics to Announce Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy, on May 5, 2026

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn

Sign up for:

Yemen Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.